Mission & Goals

The company’s mission is to research, develop and market oxygen-related therapies. In doing so, the company will set the standard in mitigation of loss of life or health due to lack of oxygen.

Our primary goals include making Oxycyte the first oxygen carrier for traumatic brain injury, developing topical oxygen carrier gels and achieving profitability through licensing.

 

 

 

 

 

 

 

  • Oxygen Biotherapeutics Introduces DERMACYTE(r) Oxygenating Eye Complex,An Oxygen-rich Serum to Reduce the Appearance of Fine Lines Around Eyes

  • DURHAM, NC, July 28, 2010 - Oxygen Biotherapeutics, Inc. (NASDAQ & SIX Swiss Exchange: OXBT) today introduced its new, innovative skin care product, DERMACYTE(r) Oxygenating Eye Complex, a smooth, delicate eye serum specially designed to refresh, hydrate and restore the appearance of youth to the eye contour area. Beginning August 9th, retail orders can be placed on Oxygen Biotherapeutics' secure website at www.BuyDermacyte.com. Orders made by August 31st can receive free shipping in the U.S. and Canada by using the Code SHIPCOMPLEX10. More...

Quick Links